Cell and Tissue Banking

, Volume 6, Issue 3, pp 191–200 | Cite as

Tissue Safety in View of CJD and Variant CJD

Article

Abstract

Epidemiological studies on human transmissible spongiform encephalopathies (Creutzfeldt–Jakob Disease, CJD) have shown that the agent could be transmitted by highly infectious tissues like brain, spinal cord or retina and medicinal products derived from these tissues (i.e. human growth hormone, dura mater). A few cases of transmission of CJD by neurosurgical instruments have been reported. The transmission of the agent of variant CJD, which is suspected to be transmitted by BSE-contaminated food, by blood transfusion implies that in contrast to the agent of classical CJD this agent can also be transmitted by organs and tissues other than nerve tissues. Health authorities have implemented guidelines to reduce the risk of transmission of human and animal TSE by human and veterinary medicinal products. The high resistance of TSE agents against physical or chemical treatment hamper the development of highly efficient inactivation steps in the production of medicinal products. Donor selection is considered as an efficient measure to reduce the risk of TSE transmission. However, the development of rapid, sensitive and specific diagnostic test systems is urgently required to test blood, organs and tissue of donors.

Keywords

Creutzfeldt–Jakob disease Diagnostic tests Donor selection Iatrogenic transmission TSE 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguzzi, A., Heikenwalder, M., Miele, G. 2004Progress and problems in the biology, diagnostics, and therapeutics of prion diseasesJ. Clin. Invest114153160CrossRefPubMedGoogle Scholar
  2. Alpérovitch, A., Zerr, I., Pocchiari, M., Mitrova, E., Pedro Cuesta, J., Hegyi, I., Collins, S., Kretzschmar, H.A., Duijn, C., Will, R.G. 1999Codon 129 prion protein genotype and sporadic Creutzfeldt–Jakob diseaseLancet35316731674CrossRefPubMedGoogle Scholar
  3. Armstrong, R.A., Cairns, N.J., Ironside, J.W., Lantos, P.L. 2002Quantification of vacuolation (‘spongiform change’), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt–Jakob diseaseNeuropathol. Appl. Neurobiol28129135PubMedGoogle Scholar
  4. Bateman, D., Hilton, D., Love, S., Zeidler, M., Beck, J., Collinge, J. 1995Sporadic Creutzfeldt–Jakob disease in a 18-year-old in the UKLancet34611551156CrossRefGoogle Scholar
  5. Beekes, M., Mielke, M., Pauli, G., Baier, M., Kurth, R. 2004Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulationsContrib. Microbiol11117135PubMedGoogle Scholar
  6. Blajchman, M.A., Goldman, M., Webert, K.E., Vamvakas, E.C., Hannon, J., Delage, G. 2004Proceedings of a consensus conference: the screening of blood donors for variant CJDTransfus. Med. Rev187392CrossRefPubMedGoogle Scholar
  7. Bosque, P.J., Ryou, C., Telling, G., Peretz, D., Legname, G., DeArmond, S.J., Prusiner, S.B. 2002Prions in skeletal muscleProc. Natl. Acad. Sci. USA9938123817CrossRefPubMedGoogle Scholar
  8. Brandel, J.P., Preece, M., Brown, P., Croes, E., Laplanche, J.L., Agid, Y., Will, R., Alpérovitch, A. 2003Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UKLancet362128130CrossRefPubMedGoogle Scholar
  9. Brandner, S. 2003CNS Pathogenesis of prion diseasesBr. Med. Bull66131139CrossRefPubMedGoogle Scholar
  10. Britton, T.C., al-Sarraj, S., Shaw, C., Campbell, T., Collinge, J. 1995Sporadic Creutzfeldt–Jakob disease in a 16-year-old in the UKLancet3461155CrossRefGoogle Scholar
  11. Brown, P., Will, R.G., Bradley, R., Asher, D.M., Detwiler, L. 2001Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: backgroundevolution, and current concernsEmerg. Infect. Dis7616PubMedGoogle Scholar
  12. Brown, S.A., Merritt, K., Woods, T.O., Busick, D.N. 2005Effects on instruments of the World Health Organization – recommended protocols for decontamination after possible exposure to transmissible spongiform encephalopathy-contaminated tissueJ. Biomed. Mater. Res. B Appl. Biomater72186190CrossRefPubMedGoogle Scholar
  13. Bruce, M.E., McConnell, I., Will, R.G., Ironside, J.W. 2001Detection of variant CJD infectivity in extraneural tissuesLancet358208209CrossRefPubMedGoogle Scholar
  14. Collinge, J. 1999Variant Creutzfeldt–Jakob diseaseLancet354317323CrossRefPubMedGoogle Scholar
  15. Collins, S., Law, M.G., Fletcher, A., Boyd, A., Kaldor, J., Masters, C.L. 1999Surgical treatment and risk of sporadic Creutzfeldt–Jakob disease: a casecontrol studyLancet353693697CrossRefPubMedGoogle Scholar
  16. Collins, S.J., Lawson, V.A., Masters, C.L. 2004Transmissible spongiform encephalopathiesLancet3635161CrossRefPubMedGoogle Scholar
  17. CPMP 1996. Note for Guidance on Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents Via Medicinal Products – CPMP/BWP/877/96. Google Scholar
  18. CPMP 2001. Note for Guidance on Plasma Derived Medicinal Products – CPMP/BWP/269/95 rev. 3, 2001. Google Scholar
  19. CPMP 2004. Note for Guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMEA/410/01 Rev. 2 – October 2003) adopted by the Committee of Proprietary Medicinal Products (CPMP) and by the Committee for Veterinary Medical products (CVMP) Official. J. Euro. Union C 24/6–19. Google Scholar
  20. Dalsgaard, N.J. 2002Prion Diseases. An OverviewAPMIS110313CrossRefPubMedGoogle Scholar
  21. Darbord, J. 1999Inactivation of prions in daily medical practiceBiomed. Pharmacother533438CrossRefPubMedGoogle Scholar
  22. Diringer, H. 1996Creutzfeldt–Jakob diseaseLancet34713321333CrossRefGoogle Scholar
  23. Eastlund, T., Strong, D.M. 2004

    Infectious disease transmission through tissue transplantation

    Phillips, G.O. eds. Advances in Tissue BankingWorld ScientificSingapore51131
    Google Scholar
  24. Epid Bulletin 2005. 8: 70.Google Scholar
  25. Fichet, G., Comoy, E., Duval, C., Antloga, K., Dehen, C., Charbonnier, A., McDonnell, G., Brown, P., Lasmezas, C.I., Deslys, J.P. 2004Novel methods for disinfection of prion-contaminated medical devicesLancet364521526CrossRefPubMedGoogle Scholar
  26. Fishman, J.A. 2001Infection in xenotransplantationJ. Card. Surg16363373PubMedGoogle Scholar
  27. Goldfarb, L.G., Cervenakova, L., Gajdusek, D.C. 2004Genetic studies in relation to kuru: an overviewCurr. Mol. Med4375384CrossRefPubMedGoogle Scholar
  28. Goodman, J.L. 2004The safety and availability of blood and tissues – progress and challengesN. Engl. J. Med351819821CrossRefPubMedGoogle Scholar
  29. Head, M.W., Ritchie, D., Smith, N., McLoughlin, V., Nailon, W., Samad, S., Masson, S., Bishop, M., McCardle, L., Ironside, J.W. 2004Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt–Jakob disease: an immunohistochemical, quantitativeand biochemical studyAm. J. Pathol164143153PubMedGoogle Scholar
  30. Hill, A.F., Butterworth, R.J., Joiner, S., Jackson, G., Rossor, M.N., Thomas, D.J., Frosh, A., Tollev, N., Bell, J.E., Spencer, M., King, A., Al-Saarj, S., Ironside, J.W., Lantos, P.L., Collinge, J. 1999Investigation of variant Creutzfeldt–Jakob disease and other human prion diseases with tonsil biopsy samplesLancet353183189PubMedGoogle Scholar
  31. Hilton, D.A., Father, E., Edwards, P.,  et al. 1998Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob diseaseLancet352703704CrossRefPubMedGoogle Scholar
  32. Hilton, D.A., Ghani, A.C., Conyers, L., Edwards, P., McCardle, L., Penney, M., Ritchie, D., Ironside, J.W. 2002Accumulation of prion protein in tonsil and appendix: review of tissue samplesBMJ325633634CrossRefPubMedGoogle Scholar
  33. Honig, J.F., Merten, H.A. 2000Risk of transmission of agents associated with Creutzfeldt–Jakob disease and bovine spongiform encephalopathyPlast. Reconstr. Surg1052273PubMedGoogle Scholar
  34. Houston, F., Foster, J.D., Chong, A., Hunter, N., Bostock, C.J. 2000Transmission of BSE by blood transfusion in sheepLancet3569991000CrossRefPubMedGoogle Scholar
  35. Hunter, N. 2003Scrapie and experimental BSE in sheepBr. Med. Bull66171183CrossRefPubMedGoogle Scholar
  36. Ironside, J.W., Head, M.W. 2003Variant Creutzfeldt–Jakob disease and its transmission by bloodJ. Thromb. Haemostasis114791486CrossRefGoogle Scholar
  37. Ironside, J.W., Hilton, D.A., Ghani, A., Johnston, N.J., Conyers, L., McCardle, L.M., Best, D. 2000Retrospective study on prion-protein accumulation in tonsil and appendix tissuesLancet35516931694CrossRefPubMedGoogle Scholar
  38. Ironside, J.W., McCardle, L., Horsburgh, A., Lim, Z., Head, M.W. 2002Pathological diagnosis of variant Creutzfeldt–Jakob diseaseAPMIS1107987CrossRefPubMedGoogle Scholar
  39. Jeffrey, M., Gonzalez, L. 2004Pathology and pathogenesis of bovine spongiform encephalopathy and scrapieCurr. Top. Microbiol. Immunol2846597PubMedGoogle Scholar
  40. Johnson, R.T., Gibbs, C.J. 2004Creutzfeldt–Jakob disease and related transmissible spongiform encephalopathiesN. Engl. J. Med33919942004CrossRefGoogle Scholar
  41. Lemmer, K., Mielke, M., Pauli, G., Beekes, M. 2004Decontamination of surgical instruments from prion proteins: in vitro studies on the detachmentdestabilization and degradation of PrPsc bound to steel surfacesJ. Gen. Virol8538053816CrossRefPubMedGoogle Scholar
  42. Llewelyn, C.A., Hewitt, P.E., Knight, R.S.G., Amar, K., Cousens, S., Mackenzie, J., Will, R.G. 2004Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusionLancet363417421PubMedGoogle Scholar
  43. McCullough, J., Anderson, D., Brookie, D., Bouchard, J.P., Fergusson, D., Joly, J., Kenny, N., Lee, D., Megânn, H., Page, D., Reinharz, D., Williams, J.R., Wilson, K. 2004Consensus conference on vCJD screening of blood donors: report of the panelTransfusion44675683CrossRefPubMedGoogle Scholar
  44. Murphy, E.L., David Connor, J., McEvoy, P., Hirschler, N., Busch, M.P., Roberts, P., Nguyen, K.A., Reich, P. 2004Estimating blood donor loss due to the variant CJD travel deferralTransfusion44645650CrossRefPubMedGoogle Scholar
  45. Peden, A.H., Head, M.W., Ritchie, D.L., Bell, J.E., Ironside, J.W. 2004Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patientLancet364527529CrossRefPubMedGoogle Scholar
  46. Prusiner, S.B. 2001Shattuck lecture – neurodegenerative diseases and prionsN. Engl. J. Med34415161526CrossRefPubMedGoogle Scholar
  47. Race, R., Jenny, A., Sutton, D. 1998Scrapie infectivity and proteinase K-resistant prion protein in sheep placentabrain, spleen, and lymph node: implications for transmission and antemortem diagnosisJ. Infect. Dis178949953PubMedGoogle Scholar
  48. Ramasamy, I. 2004The risk of accidental transmission of transmissible spongiform encephalopathy: identification of emerging issuesPublic Health118409420CrossRefPubMedGoogle Scholar
  49. Ramasamy, I., Law, M., Collins, S., Brooke, F. 2003Organ distribution of prion proteins in variant Creutzfeldt-Jakob diseaseReview. Lancet Infect. Dis3214222CrossRefGoogle Scholar
  50. Ritchie, D.L., Head, M.W., Ironside, J.W. 2004Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt–Jakob disease patients using paraffin-embedded tissue blottingNeuropathol. Appl. Neurobiol30360368CrossRefPubMedGoogle Scholar
  51. Safar, J.G., Geschwind, M.D., Deering, C., Didorenko, S., Sattavat, M., Sanchez, H., Serban, A., Vey, M., Baron, H., Giles, K., Miller, B.L., Dearmond, S.J., Prusiner, S.B. 2005Diagnosis of human prion diseaseProc. Natl. Acad. Sci. USA10235013506CrossRefPubMedGoogle Scholar
  52. Scott, M.R., Peretz, D., Nguyen, H.A.B., Armond, S.J., Prusiner, S.B. 2005Transmission barriers for bovineovineand human prions in transgenic miceJ. Virol7952595271CrossRefPubMedGoogle Scholar
  53. Sigurdson, C.J., Miller, M.W. 2003Other animal prion diseasesBr. Med. Bull66199212CrossRefPubMedGoogle Scholar
  54. Srinivasan, A., Burton, E.C., Kuehnert, M.J., Rupprecht, C., Sutker, W.L., Ksiazek, T.G., Paddock, C.D., Guarner, J., Shieh, W.J., Goldsmith, C., Hanlon, C.A., Zoretic, J., Fischbach, B., Niezgoda, M., El-Feky, W.H., Orciari, L., Sanchez, E.Q., Likos, A., Klintmalm, G.B., Cardo, D., LeDuc, J., Chamberland, M.E., Jernigan, D.B., Zaki, S.R. 2005Rabies in transplant recipients investigation team. Transmission of rabies virus from an organ donor to four transplant recipientsN. Engl. J. Med35211031111CrossRefPubMedGoogle Scholar
  55. Taylor, D.M. 1999Inactivation of prions by physical and chemical meansJ. Hosp. Infect43S6976CrossRefPubMedGoogle Scholar
  56. Taylor, D.M. 2003Preventing accidental transmission of human transmissible spongiform encephalopathiesBr. Med. Bull66293303CrossRefPubMedGoogle Scholar
  57. Thomzig, A., Kratzel, C., Lenz, G., Krüger, D., Beekes, M. 2003Widespread PrPsc accumulation in muscles of hamsters orally infected with scrapieEMBO Rep4530533CrossRefPubMedGoogle Scholar
  58. Thomzig, A., Schulz-Schaeffer, W., Kratzel, C., Mai, J., Beekes, M. 2004Preclinical deposition of pathological prion protein PrPsc in muscles of hamsters orally exposed to scrapieJ. Clin. Invest11314651472CrossRefPubMedGoogle Scholar
  59. Trevitt, C.R., Singh, P.N. 2003Variant Creutzfeldt–Jakob disease: pathology, epidemiology, and public health implicationsAm. J. Clin. Nutr78651S656SPubMedGoogle Scholar
  60. Verdrager, J. 1999Risk of transmission of BSE via drugs of bovine originLancet35413041305CrossRefGoogle Scholar
  61. Ward, H.J., Everington, D., Croes, E.A., Alperovitch, A., Delasnerie-Laupretre, N., Zerr, I., Poser, S., Duijn, C.M. 2002Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controlsNeurology59543548PubMedGoogle Scholar
  62. Wenz, B., Oesch, B., Horst, M. 2001Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine boneBiomaterials2215991606CrossRefPubMedGoogle Scholar
  63. Will, R.G. 2003Acquired prion disease: iatrogenic CJD, variant CJD, kuruBr. Med. Bull66255265CrossRefPubMedGoogle Scholar
  64. Zerr, I., Poser, S. 2002Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory testsAPMIS1108898CrossRefPubMedGoogle Scholar
  65. Zerr, I., Schulz-Schaeffer, W.J., Giese, A., Bodemer, M., Schröter, A., Henkel, K., Tschampa, H., Windl, O., Pfahlberg, A., Steinhoff, B., Gefeller, O., Kretzschmar, H.A., Poser, S. 2000aCurrent clinical diagnosis of CJD: identification of uncommon variantsAnn. Neurol48323329CrossRefGoogle Scholar
  66. Zerr, I., Brandel, J.P., Masullo, C., Wientjens, D., de Silva, R., Zeidler, M., Granieri, E., Sampaolo, S., van Duijn, C., Delasnerie-Laupretre, N., Will, R., Poser, S. 2000bEuropean surveillance on Creutzfeldt–Jakob disease: a case control study for medical risk factorsJ. Clin. Epidemiol53747754CrossRefGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Center for Biological SafetyRobert Koch-InstitutBerlinGermany

Personalised recommendations